Stocks to buy

There’s so much to consider when looking for stocks to sell. Will there or won’t there be another housing market crash? The answer is that nobody knows with precise certainty. Doomsdayers claim that weaker stocks, a recession, higher mortgage rates, and a cooling jobs market could conspire to expose massive unseen cracks. Maybe they’re right.
0 Comments
Despite all the skeptics claiming that it has gone up “too far, too fast,” Nvidia (NASDAQ:NVDA) continues to climb, as investors wager that the chip maker will benefit from the artificial intelligence megatrend. Year-to-date, NVDA stock is up by nearly 93%. While another near-doubling in price may not be just around the corner, a further
0 Comments
Talking heads warn a recession is imminent in America. The majority of these people appear to either have academic backgrounds or be economists who advise large banks without actually making trading decisions themselves. But many of the country’s most successful investors — including multi-billionaires George Soros, Ken Griffin, Steve Cohen, and Warren Buffett — have
0 Comments
With so much interest in artificial intelligence thanks in large part to the introduction of chatbot protocol ChatGPT, investors may want to consider AI stocks with dividends to facilitate diversified and potentially safer exposure to the innovation. Fundamentally, these enterprises offer the best of both worlds: capital gains potential on advancing digitalization initiatives and passive
0 Comments
Although financial advisors often direct you to established, reliable enterprises, in some cases, you can find compelling ideas among the best stocks under $10. To be fair, such companies tend to be more volatile than your standard blue-chip fare. On the other hand, should the masses catch on, these cheaply priced securities offer incredible upside
0 Comments
Last year was a rough one for growth stocks, as investors shied away from risk in the face of rising interest rates. But in 2023, investors are once again on the hunt for companies with above-average growth rates. This is evidenced by the performance of the Vanguard Growth Index Fund (NYSEARCA:VUG) versus that of the
0 Comments
The alternative energy space has come under pressure recently amid concerns about a potential slowdown in demand in China. That may be true in the short-term. However, rising electric vehicle (EV) demand will create a long-term growth story, making these three lithium stocks to buy good choices to profit from the current correction. Specifically, Chinese
0 Comments
While there are plenty of highly popular dividend stocks out there to choose from, sometimes the best opportunities are found where few others are looking. This is because less attention in the dividend investing community can result in greater inefficiency in pricing. This often yields compelling buying opportunities. Popular dividend stocks are often popular for
0 Comments
Nvidia (NASDAQ:NVDA) stock stands to benefit immensely from the ongoing AI race. Shares are up 89% since the start of the year. And the momentum is not slowing. The semiconductor company makes innovative graphics processing units for various applications. Nvidia’s GPUs are particularly well-suited for AI as they can handle large amounts of data in
0 Comments
Nvidia (NASDAQ:NVDA) stock is among the year’s strongest performers. The stock is up almost 132% during the last six months, an astounding return by all measures. The momentum in the artificial intelligence (AI) industry shows no signs of decelerating as the race to develop advanced technologies intensifies. As Nvidia works with most companies active in
0 Comments
Forever battery stocks should be a part of your portfolio. After all, solid-state batteries, or the “forever battery,” could be a game-changer. According to InvestorPlace contributor Luke Lango, “…they represent one of the most promising technological breakthroughs on the 2020s. Solid-state batteries could be the key to making our phones sustain power for days… enabling our smartwatches to
0 Comments
Biotech stock fortunes hinge upon potential, progress, and the ultimate realization of drugs and devices that treat diseases. Stringent regulatory processes and long development times result in substantial costs. Those costs are subsidized on the back end upon commercial success, often leading to extremely high sales. Investing in biotech stocks is often about identifying the next
0 Comments